Can an Already Approved Drug Treat Alzheimer's Disease?

/PRNewswire/ -- The race to develop drugs to treat Alzheimer's disease, which currently affects an estimated 6 million Americans, has been slow-going. Now,...

Related Keywords

California ,United States ,San Francisco ,Kelly Zalocusky ,Phil Nova ,Misha Zilberter ,Silvia Pineda ,Celine Wang ,Richardj Hodes ,Yadong Huang ,Tomiko Oskotsky ,Bin Chen ,Ishan Paranjpe ,Benjamin Glicksberg ,Marina Sirota ,Alice Taubes ,Julie Langelier ,Yanxia Hao ,Seo Yeon Yoon ,Nicole Koutsodendris ,Mesude Bicak ,Maureen Balestra ,Idot Kosti ,Emily Aery Jones ,William Chang ,Krishna Choudhary ,Brian Grone ,Fayzan Chaudhry ,Gladstone Center ,University Of California ,Bakar Computational Health Sciences Institute ,Icahn School Of Medicine At Mount Sinai ,National Institutes Of Health ,National Institute On ,Mount Sinai Health System ,Gladstone Senior Investigator Yadong Huang ,Nature Aging ,National Institutes ,Alternative Approach ,Translational Advancement ,Real World Evidence Supporting ,Computational Repurposing ,Nuo Chen ,Jessica De Freitas ,Icahn School ,Gladstone Institutes ,Associate Director ,